Short Interest in AB Science S.A. (OTCMKTS:ABSCF) Rises By 195.3%

AB Science S.A. (OTCMKTS:ABSCF) saw a large growth in short interest in March. As of March 15th, there was short interest totalling 62,900 shares, a growth of 195.3% from the February 29th total of 21,300 shares. Based on an average daily volume of 14,400 shares, the short-interest ratio is currently 4.4 days.

AB Science Price Performance

AB Science stock opened at $2.70 on Thursday. The firm has a fifty day simple moving average of $3.95 and a two-hundred day simple moving average of $4.51. AB Science has a twelve month low of $2.55 and a twelve month high of $3.84.

About AB Science

AB Science SA, a pharmaceutical company, engages in the research, development, and marketing of protein kinase inhibitors for use in human and veterinary medicines. Its lead compound is the masitinib, a tyrosine kinase inhibitor that is in Phase III clinical trials for the treatment of prostate and pancreatic cancer, amyotrophic lateral sclerosis, multiple sclerosis, Alzheimer's, severe asthma, and mastocytosis diseases, as well as in Phase II clinical trial to treat Covid-19.